Merck KGaA (OTCMKTS:MKGAF) Shares Down 4.5% – Should You Sell?

Merck KGaA (OTCMKTS:MKGAF) was down 4.5% on Wednesday . The company traded as low as $139.7250 and last traded at $139.7250. Approximately 19 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 848 shares. The stock had previously closed at $146.31.

Merck KGaA Stock Performance

The company’s 50-day moving average price is $137.30 and its two-hundred day moving average price is $133.27. The company has a market cap of $19.08 billion, a P/E ratio of 22.53 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.